«One to 10 cats out of every 10,000 vaccinated
against infectious diseases develop cancer at the vaccine injection site,» said Julie Levy, the Maddie's ® Professor of Shelter Medicine at the University of Florida College of Veterinary Medicine.
Not exact matches
PaxVax is a fully integrated specialty vaccine company committed to
developing and commercializing innovative vaccines
against infectious diseases.
There is consistent evidence of a protective effect of exclusive breast feeding
against diarrhoeal
disease in the first 4 — 6 months of life.4 Likely causes are the immune properties of breast milk and less exposure to pathogens in contaminated milk, food, bottles, or teats.5 Contamination and inadequate sterilisation pose less of a problem in
developed than
developing countries, and this explains the greater protection of breast feeding in
developing countries where poverty, poor hygiene, and
infectious diseases are common.
With that in mind, Jos Ribeiro of the National Institute of Allergy and
Infectious Disease and colleagues decided to try
developing a vaccine
against leishmaniasis.
The company is
developing immunotherapies for cancer and prophylactic vaccines
against infectious diseases, both based on RNA molecules.
While the biodefense enterprise is awash in cash, experts have repeatedly told the government that BARDA's $ 100 million annual budget is too tiny for its ambitious mission:
developing and acquiring vaccines
against a host of deadly
infectious diseases.
An
infectious diseases researcher at Baylor College of Medicine in Houston, Texas, Hotez is
developing shots
against diseases in poorer countries such as hookworm and schistosomiasis.
The scientific work at the HZI Department of Vaccinology and Applied Microbiology includes the elucidation of mechanisms of host responses to infection and vaccination, discovering new mucosal adjuvants, and
developing and validating vaccines
against specific
infectious diseases.
NIAID's biodefense research is integrated into its larger emerging and re ‐ emerging
infectious diseases portfolio that uses sophisticated genomic and proteomic platforms focused on
developing broad ‐ spectrum therapies effective
against entire classes of pathogens.
Dr. Alessandro Sette has devoted more than 30 years of study towards understanding the immune response, measuring immune activity, and
developing disease intervention strategies
against cancer, autoimmunity, allergy, and
infectious diseases.
Working through a number of global collaborations, we are
developing this necessary infrastructure — scientific, technical and institutional — to support the use of genomics as a tool in the fight
against infectious diseases.
And just as a
developing puppy needs immunizations
against infectious diseases, he also requires social and educational «immunizations» to prevent him from
developing behavior and temperament problems.
These antibodies help protect
against infectious disease until the kitten's own immune system
develops.